文献リスト

1) Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935; 29: 181-91

2) Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980; 50: 113-6

3) 杉本 修, 青野敏博. 本邦における多嚢胞性卵巣症候群の診断基準設定に関する小委員会(平成2年～平成4年度)検討結果報告. 日産婦誌. 1993; 45: 1359-67

4) 吉村泰典. 本邦における多嚢胞性卵巣症候群の新しい診断基準. 日産婦誌. 2007; 59: 1131

5) 白石康子, 平野由紀, 島田和彦, 他. 多嚢胞性卵巣症候群(PCOS)婦人に対する不妊治療成績の検討. 日産婦栃木地方部会雑誌. 2004; 31: 8-14

6) Hughes E, Collins J, Vandekerckhove P. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome. Cochrane Database Syst Rev. 2000; (2): CD000087

7) Donesky BW, Adashi EY. Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil Steril. 1995; 63: 439-63

8) Hirano Y, Shibahara H, Takamizawa S, et al. Application of transvaginal hydrolaparoscopy for ovarian drilling using Nd: YAG laser in infertile women with polycystic ovary syndrome. Reprod Med Biol. 2003; 2: 37-40

9) Shibahara H, Hirano Y, Kikuchi K, et al. Postoperative endocrine alterlations and clinical outcome of infertile women with polycystic ovary syndrome after transvaginal hydrolaparoscopic ovarian drilling. Fertil Steril. 2006; 85: 244-6

10) Shibahara H, Hirano Y, Suzuki M. Transvaginal hydrolaparoscopic ovarian drilling for infertile women with polycystic ovary syndrome. Cur Wom Health Rev. 2006; 2: 91-5

11) Moran C, Huerta R, Conway-Myers BA, et al. Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome. Fertil Steril. 2001; 75: 625-8

12) Dunaif A, Wu X, Lee A, et al. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab. 2001; 281E: 392-9

13) Moghetti P, Castello R, Wegri C, et al. Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17, 20-lyase activity. J Clin Endocrinol Metab. 1996; 81: 881-6

14) Nestler JE, Powers LP, Matt DW, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991; 72: 83-9

15) Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipotrophy and obesity. Nat Med. 2001; 7: 941-6

16) Orio F Jr, Palomba S, Cascella T, et al. Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88: 2619-23

17) Panidis D, Kourtis A, Farmakiotis D, et al. Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod. 2003; 18: 1790-6

18) Ducluzeau PH, Cousin P, Malvoisin E, et al. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88: 3626-31

19) Ardawi MS, Rouzi AA. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril. 2005; 83: 1708-16

20) Scheen AJ. Perspective in the treatment of insulin resistance. Hum Reprod. 1997; 12 Suppl 1: 63-71

21) Kashyap S, Wells GA, Rosenwaks Z. Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Hum Reprod. 2004; 11: 2474-83

22) Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetogia. 1985; 28: 412-9

23) Shibahara H, Kikuchi K, Hirano Y, et al. Increase of multiple pregnancies caused by ovulation induction with gonadotropin in combination with metformin in infertile women with polycystic ovary syndrome. Fertil Steril. 2007; 87: 1487-90

24) Thatcher SS, Jackson EM. Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertil Steril. 2006; 85: 1002-9

25) Glueck CJ, Phillips H, Cameron D, et al. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril. 2001; 87: 524-9

26) Jakubowicz DJ, Iuorno MJ, Jakubowicz S, et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87: 524-9

27) Schachter M, Raziel A, Friedler S, et al. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Hum Reprod. 2003; 18: 721-7

28) Seppala M, Riittinen L, Julkunen M, et al. Structural studies, localization in tissue and clinical aspects of human endometrial proteins. J Reprod Fertil. 1988; 36 Suppl: 127-41

29) Steer CV, Tan SL, Dillon D, et al. Vaginal color Doppler assessment of uterine artery impedance correlates with immunohistochemical markers of endometrial receptivity required for the implantation of an embryo. Fertil Steril. 1995; 63: 101-8

30) Glueck CJ, Goldenberg N, Wang P, et al. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod. 2004; 19: 510-21

31) Glueck CJ, Goldenberg N, Pranikoff J, et al. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod. 2004; 19: 1323-30

32) Glueck CJ, Wang P. Metformin before and during pregnancy and lactation in polycystic ovary syndrome. Expert Opin Drug Saf. 2007; 6: 191-8

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp